3-间甲苯氧基丙酸 | 25173-36-8

• 物质功能分类: 有机原料 - 羧酸类化合物及衍生物
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3-间甲苯氧基丙酸
• 中文别名: 3-(3-甲基苯氧基)丙酸
• 英文名称: 3-<3-Methyl-phenoxy>-propionsaeure
• 英文别名: β-(m-Tolyloxy)propionic acid；3-(3-Methylphenoxy)propanoic acid
• CAS: 25173-36-8
• 化学式: C₁₀H₁₂O₃
• mdl: MFCD00642411
• 分子量: 180.203
• InChiKey: CMDDTCGPFWGGTB-UHFFFAOYSA-N

物化性质

• 熔点：
  105 °C
• 沸点：
  295.5±15.0 °C(Predicted)
• 密度：
  1.145±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 危险等级：
  IRRITANT
• 海关编码：
  2918990090

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 3-(3-Methylphenoxy)propanoic acid
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 3-(3-Methylphenoxy)propanoic acid
CAS number: 25173-36-8

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C10H12O3
Molecular weight: 180.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-间甲苯氧基丙酸 在 硫酸 potassium permanganate 作用下， 反应 3.0h， 生成 4-氧代苯并二氢吡喃-7-羧酸
  参考文献：
  名称：

  Darmanaden, R.; Dhanutirto, H.; Castel, J., Farmaco, Edizione Scientifica, 1984, vol. 39, # 10, p. 876 - 887

  摘要：

  DOI：
• 作为产物：
  描述：

  3-(m-tolyloxy)propionitrile. 在 盐酸 作用下， 以 水 为溶剂， 以89%的产率得到3-间甲苯氧基丙酸
  参考文献：
  名称：

  酸活化蒙脱石K-10介导的分子内酰化：简单方便地合成4-色满酮

  摘要：

  3-芳氧基丙酸在 AA.Mont.K-10 的存在下在甲苯中回流 30-45 分钟，以良好到极好的产率进行分子内环化。在邻位、间位、对位带有各种取代基的苯基环会发生这种环化反应。该方法涉及简单的后处理，适用于大规模制备。经多相酸处理的催化剂可以再生并最多使用三个循环，而活性损失最小。

  DOI：

  10.1016/j.tetlet.2021.153372

文献信息

• [EN] TARGETED PROTEIN DEGRADATION<br/>[FR] DÉGRADATION CIBLÉE DE PROTÉINES
  申请人：C4 THERAPEUTICS INC

  公开号：WO2020132561A1

  公开（公告）日：2020-06-25

  This invention provides pharmaceutical protein degraders and E3 ubiquitin ligase binders for therapeutic applications as described further herein.

  这项发明提供了用于治疗应用的药用蛋白质降解剂和E3泛素连接酶结合物。
• Copper-Catalyzed Asymmetric Hydroboration of 2<i>H</i>-Chromenes Using a Chiral Diphosphine Ligand
  作者：Xiufen Li、Chaoqiong Wang、Jianqiao Song、Zhihong Yang、Guofu Zi、Guohua Hou

  DOI：10.1021/acs.joc.9b01109

  日期：2019.7.5

  hydroboration of 2H-chromenes catalyzed by the complex of CuCl and diphosphine ligand (S,R)-DuanPhos has been realized under mild conditions to produce 3-boryl chromans, achieving good yields and excellent enantioselectivities up to 96% ee. This work provides an efficient approach to the synthesis of chiral 3-boryl chromans and derivatives.

  CuCl和二膦配体（S，R）-DuanPhos的络合物催化的2 H-色烯的高度区域选择性不对称氢硼化已在温和条件下产生3-硼烷色氨酸，获得了良好的收率和高达96％ee的优异对映选择性。这项工作为合成手性3-硼基苯并二氢吡喃及其衍生物提供了一种有效的方法。
• Novel Indoline Compounds
  申请人：LEBRETON Luc

  公开号：US20080119465A1

  公开（公告）日：2008-05-22

  Sulfonylindoline compounds of formula I, wherein R1 through R4, Y and Z have defined meanings, a process for preparation of such compounds, and the use as pharmaceutically active substances, particularly for the treatment or inhibition of neurodegeneration, cardiovascular disease, inflammatory disease, hypercholesterolemia, dyslipidemia, obesity or diabetes.

  公式I的磺胺基吲哚化合物，其中R1至R4，Y和Z具有定义的含义，一种制备这种化合物的过程，以及用作药用活性物质，特别用于治疗或抑制神经退行性疾病、心血管疾病、炎症性疾病、高胆固醇血症、血脂异常、肥胖或糖尿病。
• LXR receptor modulators
  申请人：Lebreton Luc

  公开号：US20070099960A1

  公开（公告）日：2007-05-03

  Benzenesulfonamide derivative compounds corresponding to the general formula (I): and their pharmaceutically acceptable addition salts; a process for preparation of such compounds; pharmaceutical compositions containing such compounds, and the use of such compounds as a pharmacologically active substance, in particular in the treatment of neurodegenerative diseases, cardiovascular diseases, inflammatory diseases; hypercholesterolemia, and diabetes.

  苯磺酰胺衍生物化合物对应于通式（I）：及其药学上可接受的加合盐；制备这种化合物的方法；含有这种化合物的药物组合物；以及将这种化合物用作药理活性物质，特别是在神经退行性疾病、心血管疾病、炎症性疾病、高胆固醇血症和糖尿病治疗中的用途。
• 一种含氧杂环化合物的制备方法
  申请人：湖南华腾制药有限公司

  公开号：CN106632192A

  公开（公告）日：2017-05-10

  本发明公开了一种含氧杂环化合物4‑羟基‑5‑甲基‑3,4‑二氢‑2H‑色烯‑4‑羧酸的制备方法，以4‑甲基苯酚为起始原料，经过缩合、关环、氰化、脱TMS、水解得到目标产物，该化合物是重要的医药中间体。